Cyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Provided By Globe Newswire
Last update: Aug 10, 2022
- Oral fadraciclib demonstrated good tolerability with continuous dosing;
anticipate entering Phase 2 POC stage in 2H 2022 –
